IPHASE Emechaala Ndebanye aha Mmalite Ọbara FDA nke afọ a!

 IPHASE emechala ndebanye aha ndebanye aha ọbara FDA iji kwado ọkaibe Biopharma

IPHASE nwere obi ụtọ ịkpọsa mmecha nke ọma nke Ndebanye aha Mwube Ọbara FDA nke afọ a, na-eme ka nkwa anyị sie ike na nrube isi, ịdịmma na biopharma-arụmọrụ dị njikere.

N'okpuru ụkpụrụ FDA (21 CFR 607), ụlọ ọrụ na-etinye aka na mmepụta ọbara na ọbara- ngwaahịa ewepụtara ka achọrọ ka ịdebanye aha na ụlọ ọrụ wee depụta ngwaahịa ndị dị. Ndebanye aha a na-akwado na akụrụngwa anyị na-emezu ihe FDA chọrọ maka nrụpụta na njikwa ọbara na ọbara- ngwaahịa ewepụtara. Maka ndị mmekọ biopharmaceutical, nke a na-atụgharị n'inwe ntụkwasị obi na ịdịmma, traceability, na ike iwu nke ihe biomatrix na-akwado nyocha izizi, mmepe nyocha, na ngwa ala.

Na IPHASE, a na-ewu nrubeisi n'ime usoro ọ bụla nke usoro anyị. Anyị ka na-arara onwe anyị nye na-ebuga na-agbanwe agbanwe, ntụkwasị obi, na elu-ihe ngwọta biomatrix dị mma nke na-enyere ndị otu biopharma aka ngwa ngwa-site na nchọpụta site na mmepe-mgbe nzukọ na-agbanwe atụmanya nhazi.